Cite
HARVARD Citation
Basch, E. et al. (2016). Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial. Clinical trials. pp. 331-337. [Online].